95 related articles for article (PubMed ID: 13496181)
1. Experiments with antimalarial drugs in man. V. Experiments with an active metabolite of proguanil and an active metabolite of 5943.
ROBERTSON GI
Trans R Soc Trop Med Hyg; 1957 Nov; 51(6):488-92. PubMed ID: 13496181
[No Abstract] [Full Text] [Related]
2. Proguanil, the isolation of a metabolite with high antimalarial activity.
CROWTHER AF; LEVI AA
Br J Pharmacol Chemother; 1953 Mar; 8(1):93-7. PubMed ID: 13066702
[No Abstract] [Full Text] [Related]
3. A metabolite of paludrine with high antimalarial activity.
CARRINGTON HC; CROWTHER AF; DAVEY DG; LEVI AA; ROSE FL
Nature; 1951 Dec; 168(4288):1080. PubMed ID: 14910643
[No Abstract] [Full Text] [Related]
4. The mode of action of proguanil and related antimalarial drugs.
RYLEY JF
Br J Pharmacol Chemother; 1953 Dec; 8(4):424-30. PubMed ID: 13115632
[No Abstract] [Full Text] [Related]
5. Experiments with antimalarial drugs in man. IV. An experiment to investigate the prophylactic value of proguanil against a strain of Plasmodium falciparum known to be resistant to therapeutic treatment.
DAVEY DG; ROBERTSON GI
Trans R Soc Trop Med Hyg; 1957 Sep; 51(5):463-6. PubMed ID: 13468008
[No Abstract] [Full Text] [Related]
6. Relation between chloroguanide bioactivation to cycloguanil and the genetically determined metabolism of mephenytoin in humans.
Funck-Brentano C; Bosco O; Jacqz-Aigrain E; Keundjian A; Jaillon P
Clin Pharmacol Ther; 1992 May; 51(5):507-12. PubMed ID: 1587064
[TBL] [Abstract][Full Text] [Related]
7. Experiments with antimalarial drugs in man. I. The protective effect of proguanil (paludrine) against an East African strain of Plasmodium falciparum transmitted by Anopheles gambiae.
THOMAS AT; ROBERTSON GI; DAVEY DG
Trans R Soc Trop Med Hyg; 1953 Jul; 47(4):338-45. PubMed ID: 13090297
[No Abstract] [Full Text] [Related]
8. Action of proguanil and its metabolite on neuromuscular and synaptic transmission.
DALLEMAGNE MJ; PHILIPPOT E
Br J Pharmacol Chemother; 1955 Jun; 10(2):147-52. PubMed ID: 14389651
[No Abstract] [Full Text] [Related]
9. Experiments with antimalarial drugs in man. III. Experiments with compound 5943.
ROBERTSON GI
Trans R Soc Trop Med Hyg; 1957 Sep; 51(5):457-62. PubMed ID: 13468007
[No Abstract] [Full Text] [Related]
10. Proguanil polymorphism does not affect the antimalarial activity of proguanil combined with atovaquone in vitro.
Edstein MD; Yeo AE; Kyle DE; Looareesuwan S; Wilairatana P; Rieckmann KH
Trans R Soc Trop Med Hyg; 1996; 90(4):418-21. PubMed ID: 8882194
[TBL] [Abstract][Full Text] [Related]
11. Intrinsic efficacy of proguanil against falciparum and vivax malaria independent of the metabolite cycloguanil.
Kaneko A; Bergqvist Y; Takechi M; Kalkoa M; Kaneko O; Kobayakawa T; Ishizaki T; Björkman A
J Infect Dis; 1999 Apr; 179(4):974-9. PubMed ID: 10068594
[TBL] [Abstract][Full Text] [Related]
12. Inter-subject variability in the metabolism of proguanil to the active metabolite cycloguanil in man.
Ward SA; Watkins WM; Mberu E; Saunders JE; Koech DK; Gilles HM; Howells RE; Breckenridge AM
Br J Clin Pharmacol; 1989 Jun; 27(6):781-7. PubMed ID: 2757894
[TBL] [Abstract][Full Text] [Related]
13. Polymorphic oxidative metabolism of proguanil in a Nigerian population.
Bolaji OO; Sadare IO; Babalola CP; Ogunbona FA
Eur J Clin Pharmacol; 2002 Nov; 58(8):543-5. PubMed ID: 12451432
[TBL] [Abstract][Full Text] [Related]
14. The inhibitory action of some antimalarial drugs and related compounds on the hexokinase of yeast and of Plasmodium berghei.
FRASER DM; KERMACK WO
Br J Pharmacol Chemother; 1957 Mar; 12(1):16-23. PubMed ID: 13413145
[TBL] [Abstract][Full Text] [Related]
15. Formation of the diuretic chlorazanil from the antimalarial drug proguanil--implications for sports drug testing.
Thevis M; Geyer H; Thomas A; Tretzel L; Bailloux I; Buisson C; Lasne F; Schaefer MS; Kienbaum P; Mueller-Stoever I; Schänzer W
J Pharm Biomed Anal; 2015 Nov; 115():208-13. PubMed ID: 26226108
[TBL] [Abstract][Full Text] [Related]
16. Steady-state kinetics of proguanil and its active metabolite, cycloguanil, in man.
Edstein MD; Veenendaal JR; Scott HV; Rieckmann KH
Chemotherapy; 1988; 34(5):385-92. PubMed ID: 3180907
[TBL] [Abstract][Full Text] [Related]
17. Trends in antimalarial prescriptions in Australia 2002 to 2005.
Leggat PA
J Travel Med; 2008; 15(5):302-6. PubMed ID: 19006502
[TBL] [Abstract][Full Text] [Related]
18. The potentiation of the antimalarial activity of chloroguanide by p-aminobenzoic acid competitors.
GREENBERG J
J Pharmacol Exp Ther; 1949 Oct; 97(2):238-42. PubMed ID: 15391935
[No Abstract] [Full Text] [Related]
19. Inhibition by omeprazole of proguanil metabolism: mechanism of the interaction in vitro and prediction of in vivo results from the in vitro experiments.
Funck-Brentano C; Becquemont L; Lenevu A; Roux A; Jaillon P; Beaune P
J Pharmacol Exp Ther; 1997 Feb; 280(2):730-8. PubMed ID: 9023285
[TBL] [Abstract][Full Text] [Related]
20. Proguanil metabolism is determined by the mephenytoin oxidation polymorphism in Vietnamese living in Denmark.
Brøsen K; Skjelbo E; Flachs H
Br J Clin Pharmacol; 1993 Aug; 36(2):105-8. PubMed ID: 8398577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
